Stocktoria
New China Life Insurance Company Ltd. 601336.SS
CN · Shanghai Stock Exchange · XSHG · stock · Financial Services · website
New China Life Insurance Company Ltd. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | CN¥152.0B | CN¥68.0B | CN¥70.1B | CN¥106.9B |
| SG&A expense | CN¥2.8B | CN¥3.1B | CN¥2.4B | CN¥3.1B |
| Interest expense | — | — | CN¥60.6B | CN¥76.0B |
| Income tax | CN¥4.2B | CN¥1.9B | -CN¥3.2B | CN¥575.0M |
| Net income | CN¥36.3B | CN¥26.2B | CN¥8.7B | CN¥21.5B |
| EPS (diluted) | CN¥11.63 | CN¥8.41 | CN¥2.79 | CN¥6.89 |
| Operating cash flow | CN¥110.9B | CN¥96.3B | CN¥91.5B | CN¥88.5B |
| Free cash flow | CN¥109.4B | CN¥95.2B | CN¥89.5B | CN¥86.7B |
| Cash & equivalents | CN¥42.9B | CN¥38.5B | CN¥21.8B | CN¥17.6B |
| Total assets | CN¥1.90T | CN¥1.69T | CN¥1.40T | CN¥1.21T |
| Total debt | CN¥20.8B | CN¥31.1B | CN¥21.0B | CN¥10.9B |
| Total liabilities | CN¥1.79T | CN¥1.60T | CN¥1.30T | CN¥1.12T |
| Shareholders' equity | CN¥111.5B | CN¥96.2B | CN¥105.1B | CN¥98.0B |
Growth · year-over-year · Revenue CAGR 12.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +123.5% | -3.0% | -34.4% | — |
| Net income growth | +38.3% | +201.1% | -59.5% | — |
| EPS growth | +38.3% | +201.4% | -59.5% | — |
| Free cash flow growth | +15.0% | +6.4% | +3.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.